ReviewDegenerative neurological and neuromuscular disease2020

Re-Evaluating the Use of IFN-β and Relapsing Multiple Sclerosis: Safety, Efficacy and Place in Therapy.

Carolyn H Goldschmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.